Primary Peptides

Primary Peptides is a development stage biotech company that has developed a proprietary platform technology enabling it to identify, target, and disrupt specific protein-protein interactions leading to new peptide therapeutics for unmet medical needs. Our peptides can also replace SiRNA in many indications with improved pharmacokinetics and specificity. Primary Peptides has developed lead compounds in several neuroscience and cardiovascular indications.

MRC Technology

MRC Technology is an independent life science technology transfer charity, offering professional services toorganizations within the academic, charity, biotechnology and pharmaceutical sectors globally. Services include IP management and research and development for diagnostics, small molecules and therapeutic antibodies. MRC Technology bridges the gap between basic medical research and commercialization, helping early discoveries progress to clinical application.

Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Lawson Health Research Institute

Lawson Health Research Institute is the research institute of London Health Sciences Centre and St. Joseph's Health Care London. Working in partnership with Western University, Lawson Health Research Institute is committed to furthering scientific knowledge to advance health care around the Commercialization at Lawson is facilitated by WORLDiscoveries®, a joint venture of Lawson, Western University and Robart's Research Institute, the first Canadian technology transfer venture to open permanent satellite offices in China.

LeSun Pharmaceuticals

LeSun Pharmaceuticals is founded by Professor Shudong Wang from University of South Australia. As a foreign R&D incubating platform and transforming base, LeSun Pharmaceuticals will introduce the latest foreign research achievements into China continuously. The company is primarily focused on the discovery, development and commercialization of new drugs and offers fully integrated pharmaceuticals services for the global scientific institutions and pharmaceutical companies.
Copyright © Suzhou Yabao Pharmaceutical R&D Co.,Ltd.  苏ICP备号